Related Experiment Videos
[Cleft palate and cortico-therapy during pregnancy]
Archives Francaises De Pediatrie
|December 1, 1979
Insights
Corticosteroid therapy during early pregnancy may be linked to cleft palate development in infants. This study examines the relationship between corticosteroid exposure and cleft palate risk.
Area of Science:
- Obstetrics and Gynecology
- Pediatric Medicine
- Teratology
Background:
- Prenatal exposure to certain medications can impact fetal development.
- Corticosteroids are commonly used during pregnancy for various maternal conditions.
- Understanding potential teratogenic effects of medications is crucial for prenatal care.
Observation:
- A case study describes an infant born with a cleft palate.
- The infant's mother received corticosteroid therapy early in her pregnancy.
Findings:
- The study discusses the potential relationship between prenatal corticosteroid exposure and the occurrence of cleft palate.
- Analysis focuses on the dose and timing of corticosteroid administration in relation to the observed birth defect.
Implications:
- Findings may inform clinical guidelines regarding corticosteroid use in early pregnancy.
- Highlights the importance of evaluating medication risks versus benefits during prenatal care.
- Contributes to the understanding of environmental factors influencing craniofacial development.
Abstract:
A child with cleft palate is described who was born to a mother who received corticosteroid therapy early in pregnancy. The relationship between the cleft palate and the dose and timing of the corticosteroid therapy is discussed.